Investigations using DNA microarrays have shown that diffuse large B-cell lymphomas (DLBCL) group into at least two histologically indistinguishable, but molecularly distinct pathologies that differ ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies.

Therapeutic antibodies or immunoglobulins are becoming increasingly popular due to their targeted approach to treating various diseases, including cancer, autoimmune disorders, and infectious diseases ...